Fundz

Ag Novos Bioscience reported raising $31.5 Million in an initial SEC Form D filing, from an offering of $60 Million

PRIVATEJun 09, 2023$31.5M of $60M raised

Amount Raised

$31.5 Million

$31.5 Million sold, per SEC Form D (first sale May 26, 2023)

Round Type

Venture

RockvilleHealthcareMedical Device

Quick answer

AgNovos Bioscience raised $31.5 Million in a funding round, dated May 26, 2023. AgNovos Bioscience is based in Rockville, Maryland, United States.

How much did AgNovos Bioscience raise?
AgNovos Bioscience raised $31.5 Million in a funding round on May 26, 2023.
What does AgNovos Bioscience do?
AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease.
Where is AgNovos Bioscience based and how big is it?
AgNovos Bioscience is based in Rockville, Maryland, United States.
Who are the decision-makers at AgNovos Bioscience?
Fundz holds 1 contact at AgNovos Bioscience. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical Device around the same time

Companies in the same sectors as AgNovos Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • CurvaFix raised $24M on June 29, 2023.
  • Precision Optics Corporation raised $2.5M (Seed) on June 20, 2023.
  • Avenda Health, Inc. raised $3.5M (Series B) on June 8, 2023.
  • InspireMD raised $42M on May 12, 2023.
  • Hummingbird Healthcare raised $1.2M (Seed) on May 9, 2023.
  • Flyte raised $2.6M (Seed) on May 2, 2023.

Who to call at AgNovos Bioscience, and when

A new round usually means AgNovos Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AgNovos Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AgNovos Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AgNovos Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AgNovos Bioscience

Location

7301 CALHOUN PLACE

Rockville, Maryland, United States

About

AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. The Company’s first product, the OSSURE Local Osteo-Enhancement Procedure (LOEP) kit has been evaluated in multiple clinical studies and is available in select markets. The Company has initiated RESTORE, a randomized, controlled, prospective, single-blinded, multi-national study designed to evaluate the impact of OSSURE LOEP on the risk of secondary hip fractures. RESTORE is one of the largest prospective studies ever conducted in orthopedic traumatology. The data generated will be critical to gaining access to new markets, including the U.S. and Japan. The Company has also developed the AGN1 LOEP SV kit investigational device intended to treat stable but painful vertebral compression fractures. That device has received both a Breakthrough Device designation and an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration. AgNovos Bioscience is privately held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services located in Rockville, MD.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AgNovos Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for AgNovos Bioscience's next move

See what Strategic adds

AgNovos Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.